{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:54:01Z","timestamp":1792652041718,"version":"4.5.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/crd.0b013e31825d0a44","type":"journal-article","created":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T08:18:34Z","timestamp":1336551514000},"page":"259-263","source":"Crossref","is-referenced-by-count":115,"title":["Effects of Antihypertensive Drugs on Arterial Stiffness"],"prefix":"10.1097","volume":"20","author":[{"given":"Tanja","family":"Dudenbostel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Glasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210203","first-page":"259","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.","volume":"20","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"R3-6-20210203","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"R4-6-20210203","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2011.01.008","article-title":"ACCFAHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.","volume":"57","author":"Aronow","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.109.886655","article-title":"Arterial stiffness and cardiovascular events: the Framingham Heart Study.","volume":"121","author":"Mitchell","year":"2010","journal-title":"Circulation"},{"key":"R7-6-20210203","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1161\/CIRCULATIONAHA.104.483628","article-title":"Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults.","volume":"111","author":"Sutton-Tyrrell","year":"2005","journal-title":"Circulation"},{"key":"R8-6-20210203","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","article-title":"Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients.","volume":"37","author":"Laurent","year":"2001","journal-title":"Hypertension"},{"key":"R9-6-20210203","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jacc.2007.10.065","article-title":"Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging.","volume":"51","author":"Najjar","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R10-6-20210203","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.HYP.26.3.503","article-title":"Noninvasive pulse wave analysis for the early detection of vascular disease.","volume":"26","author":"Cohn","year":"1995","journal-title":"Hypertension"},{"key":"R11-6-20210203","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.2174\/138161205774424654","article-title":"Large artery stiffness and antihypertensive agents.","volume":"11","author":"Blacher","year":"2005","journal-title":"Curr Pharm Des"},{"key":"R12-6-20210203","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2165\/11593790-000000000-00000","article-title":"Pharmacological modulation of arterial stiffness.","volume":"71","author":"Boutouyrie","year":"2011","journal-title":"Drugs"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/HJH.0b013e32834000be","article-title":"The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials.","volume":"29","author":"Czernichow","year":"2011","journal-title":"J Hypertens"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.HYP.0000161186.55933.6b","article-title":"Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.","volume":"45","author":"Fyhrquist","year":"2005","journal-title":"Hypertension"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"R16-6-20210203","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.595496","article-title":"Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.","volume":"113","author":"Williams","year":"2006","journal-title":"Circulation"},{"key":"R17-6-20210203","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/HYPERTENSIONAHA.109.134379","article-title":"Role of pulse pressure amplification in arterial hypertension: experts opinion and review of the data.","volume":"54","author":"Avolio","year":"2009","journal-title":"Hypertension"},{"key":"R18-6-20210203","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","article-title":"Expert consensus document on arterial stiffness: methodological issues and clinical applications.","volume":"27","author":"Laurent","year":"2006","journal-title":"Eur Heart J"},{"key":"R20-6-20210203","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/01.CIR.99.18.2434","article-title":"Impact of aortic stiffness on survival in end-stage renal disease.","volume":"99","author":"Blacher","year":"1999","journal-title":"Circulation"},{"key":"R21-6-20210203","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.","volume":"55","author":"Vlachopoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R22-6-20210203","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.105.555235","article-title":"Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study.","volume":"113","author":"Mattace-Raso","year":"2006","journal-title":"Circulation"},{"key":"R23-6-20210203","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(05)67573-3","article-title":"Should beta blockers remain first choice in the treatment of primary hypertension A meta-analysis.","volume":"366","author":"Lindholm","year":"2005","journal-title":"Lancet"},{"key":"R24-6-20210203","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jacc.2008.09.046","article-title":"Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.","volume":"53","author":"Protogerou","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R26-6-20210203","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.amjhyper.2003.09.012","article-title":"Effect of different antihypertensive drug classes on central aortic pressure.","volume":"17","author":"Morgan","year":"2004","journal-title":"Am J Hypertens"},{"key":"R28-6-20210203","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/HYPERTENSIONAHA.110.155507","article-title":"Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.","volume":"57","author":"Kampus","year":"2011","journal-title":"Hypertension"},{"key":"R29-6-20210203","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/138161209787354186","article-title":"The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effects of antihypertensive drugs on pressure amplification.","volume":"15","author":"Protogerou","year":"2009","journal-title":"Curr Pharm Des"},{"key":"R31-6-20210203","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/j.1552-4604.1998.tb04417.x","article-title":"The importance of arterial compliance in cardiovascular drug therapy.","volume":"38","author":"Glasser","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"R32-6-20210203","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/HYPERTENSIONAHA.111.180497","article-title":"Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.","volume":"58","author":"Hanselin","year":"2011","journal-title":"Hypertension"},{"key":"R33-6-20210203","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/HYPERTENSIONAHA.111.183525","article-title":"Chlorthalidone versus hydrochlorothiazide: a tale of tortoises and a hare.","volume":"58","author":"Kaplan","year":"2011","journal-title":"Hypertension"},{"key":"R34-6-20210203","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/hy1001.095774","article-title":"Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindoprilindapamide combination in hypertensive patient: a comparison with atenolol.","volume":"38","author":"Asmar","year":"2001","journal-title":"Hypertension"},{"key":"R35-6-20210203","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/jmcc.1998.0867","article-title":"Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine.","volume":"31","author":"Mason","year":"1999","journal-title":"J Mol Cell Cardiol"},{"key":"R36-6-20210203","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1161\/01.CIR.90.6.2786","article-title":"Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.","volume":"90","author":"London","year":"1994","journal-title":"Circulation"},{"key":"R37-6-20210203","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00004872-200204000-00037","article-title":"Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.","volume":"20","author":"Deary","year":"2002","journal-title":"J Hypertens"},{"key":"R39-6-20210203","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/HJH.0b013e3280ac1533","article-title":"Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.","volume":"25","author":"Jiang","year":"2007","journal-title":"J Hypertens"},{"key":"R40-6-20210203","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.jhh.1001053","article-title":"Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension.","volume":"14","author":"Mahmud","year":"2000","journal-title":"J Hum Hypertens"},{"issue":"5","key":"R41-6-20210203","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.amjhyper.2004.05.023","article-title":"Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment.","volume":"17","author":"Schiffrin","year":"2004","journal-title":"Am J Hypertens"},{"key":"R42-6-20210203","first-page":"984","article-title":"Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.","volume":"118","author":"Lu","year":"2008","journal-title":"J Clin Invest"},{"key":"R43-6-20210203","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/dc09-1303","article-title":"Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study.","volume":"33","author":"Cherney","year":"2010","journal-title":"Diabetes Care"},{"key":"R44-6-20210203","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/eurjhf\/hfs033","article-title":"Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"R46-6-20210203","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/eurheartj\/ehr066","article-title":"Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.","volume":"32","author":"Verma","year":"2011","journal-title":"Eur Heart J"},{"key":"R47-6-20210203","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.HYP.0000025146.19104.FE","article-title":"Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients.","volume":"40","author":"Krum","year":"2002","journal-title":"Hypertension"},{"key":"R48-6-20210203","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjhyper.2004.08.026","article-title":"Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.","volume":"18","author":"Mahmud","year":"2005","journal-title":"Am J Hypertens"},{"key":"R49-6-20210203","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.108.119966","article-title":"Reconsidering the roles of the mineralocorticoid receptor.","volume":"53","author":"Funder","year":"2009","journal-title":"Hypertension"},{"key":"R50-6-20210203","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.109.140988","article-title":"Efficacy of spironolactone therapy in patients with true resistant hypertension.","volume":"55","author":"de Souza","year":"2010","journal-title":"Hypertension"},{"key":"R51-6-20210203","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/HYPERTENSIONAHA.107.103267","article-title":"Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.","volume":"51","author":"Savoia","year":"2008","journal-title":"Hypertension"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045415-201209000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T06:47:00Z","timestamp":1642229220000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-201209000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0b013e31825d0a44","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}